T1	REACTION_PRODUCT 127 214	4-amino-5-fluoro-3- [6-(4-methylpiperazin1 -yl)- 1H-benzimidazol-2yl]-lH-quinolin-2-one
T2	REACTION_PRODUCT 243 259	pharmaceutically
T3	REACTION_PRODUCT 483 571	4-amino-5-fluoro-3-[6- (4-methylpiperazin1-yl)- 1H-benzimidazol-2-yl]- 1H-quinolin-2-one
T4	OTHER_COMPOUND 671 674	HCC
T5	OTHER_COMPOUND 781 785	VEGF
T6	OTHER_COMPOUND 787 795	vascular
T7	OTHER_COMPOUND 824 834	fibroblast
T8	OTHER_COMPOUND 850 853	FGF
T9	OTHER_COMPOUND 868 882	derived growth
T10	OTHER_COMPOUND 891 895	PDGF
T11	OTHER_COMPOUND 937 940	HCC
T12	OTHER_COMPOUND 979 984	FGFR3
T13	REACTION_PRODUCT 1020 1021	3
T14	OTHER_COMPOUND 1045 1048	HCC
T15	OTHER_COMPOUND 1109 1112	HCC
T16	OTHER_COMPOUND 1186 1195	sorafenib
T17	OTHER_COMPOUND 1321 1324	HCC
T18	OTHER_COMPOUND 1568 1577	sorafenib
T19	OTHER_COMPOUND 1701 1710	sorafenib
T20	OTHER_COMPOUND 1751 1754	HCC
T21	OTHER_COMPOUND 1841 1844	HCC
T22	TIME 1910 1913	6.5
T23	OTHER_COMPOUND 2019 2022	HCC
T24	OTHER_COMPOUND 2055 2064	sorafenib
T25	OTHER_COMPOUND 2158 2164	months
T26	OTHER_COMPOUND 2168 2171	HCC
T27	OTHER_COMPOUND 2213 2232	sorafenib treatment
T28	OTHER_COMPOUND 2445 2448	HFS
T29	REACTION_PRODUCT 2680 2768	4-amino-5-fluoro-3- [6-(4-methylpiperazin1 -yl)- 1H-benzimidazol-2-yl]- 1Hquinolin-2-one
T30	OTHER_COMPOUND 2920 2944	hepatocellular carcinoma
T31	OTHER_COMPOUND 2946 2949	HCC
T32	OTHER_COMPOUND 2954 2959	liver
T33	OTHER_COMPOUND 3325 3334	sorafenib
T34	OTHER_COMPOUND 3515 3519	drug
T35	OTHER_COMPOUND 3665 3668	HFS
T36	OTHER_COMPOUND 3717 3725	medicine
T37	OTHER_COMPOUND 3737 3746	sorafenib
T38	REACTION_PRODUCT 3758 3849	4-Amino-5-fluoro-3 - [6-(4-methylpiperazin1 -yl)- 1H-benzimidazol-2-yl] - 1H-quinolin-2-one
T39	OTHER_COMPOUND 3991 3992	I
T40	OTHER_COMPOUND 4107 4108	I
T41	OTHER_COMPOUND 4840 4843	PCT
T42	OTHER_COMPOUND 5257 5263	growth
T43	OTHER_COMPOUND 5682 5683	I
T44	OTHER_COMPOUND 5693 5701	tyrosine
T45	OTHER_COMPOUND 5757 5761	Cdc2
T46	OTHER_COMPOUND 5801 5804	Fyn
T47	OTHER_COMPOUND 5837 5840	SRC
T48	OTHER_COMPOUND 5842 5845	FGR
T49	OTHER_COMPOUND 5847 5850	YES
T50	OTHER_COMPOUND 6072 6077	c-ABL
T51	OTHER_COMPOUND 6160 6167	Adelson
T52	OTHER_COMPOUND 6185 6191	VEGFR3
T53	OTHER_COMPOUND 6193 6199	PDGFRa
T54	OTHER_COMPOUND 6245 6252	PDGFR[3
T55	OTHER_COMPOUND 6299 6304	FGFR3
T56	OTHER_COMPOUND 6344 6349	FLT-3
T57	OTHER_COMPOUND 6351 6354	fms
T58	OTHER_COMPOUND 6360 6368	tyrosine
T59	OTHER_COMPOUND 6383 6388	Tie-2
T60	OTHER_COMPOUND 6418 6421	EGF
T61	OTHER_COMPOUND 6485 6489	Cdc2
T62	OTHER_COMPOUND 6498 6506	Fyn, Lck
T63	OTHER_COMPOUND 6511 6516	Tie-2
T64	OTHER_COMPOUND 6571 6576	c-Kit
T65	OTHER_COMPOUND 6578 6583	c-ABL
T66	OTHER_COMPOUND 6585 6591	p60src
T67	OTHER_COMPOUND 6593 6599	VEGFR3
T68	OTHER_COMPOUND 6601 6607	PDGFRa
T69	OTHER_COMPOUND 6609 6616	PDGFR[3
T70	OTHER_COMPOUND 6618 6623	FGFR3
T71	OTHER_COMPOUND 6628 6633	FLT-3
T72	OTHER_COMPOUND 6847 6860	growth factor
T73	OTHER_COMPOUND 6873 6880	VEGFR-1
T74	OTHER_COMPOUND 6930 6937	VEGFR-2
T75	OTHER_COMPOUND 6944 6952	vascular
T76	OTHER_COMPOUND 6991 6998	VEGFR-3
T77	REACTION_PRODUCT 7043 7128	4-amino-5-fluoro-3-[6-(4-methylpiperazin-l-yl)-lHbenzimidazol-2-yl]-1H-quinolin-2-one
T78	OTHER_COMPOUND 7484 7487	HCC
T79	OTHER_COMPOUND 7618 7627	sorafenib
T80	OTHER_COMPOUND 7673 7676	HCC
T81	OTHER_COMPOUND 8016 8025	sorafenib
T82	OTHER_COMPOUND 8048 8051	HCC
T83	OTHER_COMPOUND 8070 8079	sorafenib
T84	OTHER_COMPOUND 8114 8123	sorafenib
T85	REACTION_PRODUCT 8668 8753	4-amino-5-fluoro-3-[6-(4-methylpiperazin-l-yl)-lH-benzimidazol-2yl]-lH-quinolin-2-one
T86	OTHER_COMPOUND 8878 8881	HCC
T87	REACTION_PRODUCT 8925 9010	4-amino-5-fluoro-3-[6-(4-methylpiperazin-l-yl)-lHbenzimidazol-2-yl]-1H-quinolin-2-one
T88	OTHER_COMPOUND 9205 9206	I
T89	REACTION_PRODUCT 9217 9302	4-amino-5-fluoro-3-[6-(4-methylpiperazin-l-yl)-lHbenzimidazol-2-yl]-1H-quinolin-2-one
T90	REACTION_PRODUCT 9414 9499	4-amino-5-fluoro-3-[6-(4-methylpiperazin-l-yl)-lHbenzimidazol-2-yl]-1H-quinolin-2-one
T91	OTHER_COMPOUND 9543 9550	lactate
T92	REACTION_PRODUCT 9781 9866	4-amino-5-fluoro-3-[6-(4-methylpiperazin-l-yl)-lH-benzimidazol-2-yl]-lHquinolin-2-one
T93	REACTION_PRODUCT 10120 10208	4-amino-5-fluoro-3-[6-(4-methylpiperazin-l-yl)- 1H-benzimidazol-2-yl]- 1H-quinolin-2-one
T94	REACTION_PRODUCT 10511 10599	4-amino-5-fluoro-3-[6- (4-methylpiperazin1-yl)- 1H-benzimidazol-2-yl]- 1H-quinolin-2-one
T95	OTHER_COMPOUND 10977 10978	I
T96	OTHER_COMPOUND 11128 11129	I
T97	REACTION_PRODUCT 11389 11477	4-amino-5-fluoro-3- [6-(4-methylpiperazin1 -yl)- 1H-benzimidazol-2-yl]- 1Hquinolin-2-one
T98	OTHER_COMPOUND 11595 11601	weekly
T99	REACTION_PRODUCT 11653 11744	4-Amino-5-fluoro-3 - [6-(4-methylpiperazin1 -yl)- 1H-benzimidazol-2-yl] - 1H-quinolin-2-one
T100	TIME 12040 12049	11 months
T101	TIME 12051 12062	superior or
T102	TIME 12072 12081	12 months
T103	TIME 12095 12100	equal
T104	TIME 12104 12113	13 months
T105	REACTION_PRODUCT 12126 12214	4-Amino-5fluoro-3- [6-(4-methylpiperazin1 -yl)- 1H-benzimidazol-2-yl]- 1H-quinolin-2-one
T106	OTHER_COMPOUND 12588 12589	C
T107	OTHER_COMPOUND 12655 12667	hypertension
T108	OTHER_COMPOUND 12675 12678	HFS
T109	OTHER_COMPOUND 12682 12686	HFSR
T110	OTHER_COMPOUND 12763 12767	HUH7
T111	OTHER_COMPOUND 12792 12798	TKI258
T112	OTHER_COMPOUND 12991 12995	HUH7
T113	OTHER_COMPOUND 13028 13034	TKI258
T114	OTHER_COMPOUND 13074 13080	TKI258
T115	OTHER_COMPOUND 13254 13260	TKI258
T116	OTHER_COMPOUND 13382 13390	PLC/PFR/
T117	OTHER_COMPOUND 13424 13430	TKI258
T118	OTHER_COMPOUND 13471 13477	TKI258
T119	EXAMPLE_LABEL 13596 13597	1
T120	OTHER_COMPOUND 13680 13700	Hank's Balanced Sait
T121	OTHER_COMPOUND 13711 13715	HBSS
T122	OTHER_COMPOUND 13752 13768	Membrance Matrix
T123	REAGENT_CATALYST 13773 13781	Matrigel
T124	OTHER_COMPOUND 13945 13949	1640
T125	OTHER_COMPOUND 13979 13995	Fetal Calf Serum
T126	OTHER_COMPOUND 14000 14005	horse
T127	OTHER_COMPOUND 14016 14027	L-glutamine
T128	OTHER_COMPOUND 14035 14045	Penecyllin
T129	OTHER_COMPOUND 14046 14058	Streptavidin
T130	TIME 14138 14145	12 days
T131	OTHER_COMPOUND 14230 14233	day
T132	OTHER_COMPOUND 14278 14279	I
T133	TIME 14317 14324	21 days
T134	OTHER_COMPOUND 14811 14812	I
T135	OTHER_COMPOUND 14857 14862	water
T136	OTHER_COMPOUND 15115 15120	water
T137	OTHER_COMPOUND 15260 15263	SEM
T138	OTHER_COMPOUND 15696 15703	vehicle
T139	OTHER_COMPOUND 16382 16386	HBSS
T140	OTHER_COMPOUND 16423 16439	Membrance Matrix
T141	OTHER_COMPOUND 16441 16452	BD Matrigel
T142	OTHER_COMPOUND 16639 16643	RPMI
T143	OTHER_COMPOUND 16678 16688	Fetal Calf
T144	OTHER_COMPOUND 16699 16710	horse serum
T145	OTHER_COMPOUND 16715 16726	L-glutamine
T146	OTHER_COMPOUND 16734 16757	penecyllin/Streptavidin
T147	OTHER_COMPOUND 16800 16810	BioConcept
T148	OTHER_COMPOUND 16978 16979	I
T149	TIME 17017 17024	24 days
T150	OTHER_COMPOUND 17396 17398	AT
T151	OTHER_COMPOUND 17444 17451	animals
T152	OTHER_COMPOUND 17511 17512	I
T153	OTHER_COMPOUND 17557 17562	water
T154	OTHER_COMPOUND 17819 17824	water
T155	OTHER_COMPOUND 18399 18406	vehicle
T156	OTHER_COMPOUND 18817 18824	vehicle
T157	EXAMPLE_LABEL 18861 18862	3
T158	OTHER_COMPOUND 18875 18884	Dovitinib
T159	OTHER_COMPOUND 18892 18901	Sorafenib
T160	OTHER_COMPOUND 18905 18910	Adult
T161	OTHER_COMPOUND 19118 19119	I
T162	OTHER_COMPOUND 19127 19136	sorafenib
T163	OTHER_COMPOUND 19185 19188	HCC
T164	OTHER_COMPOUND 19267 19268	I
T165	OTHER_COMPOUND 19272 19281	sorafenib
T166	OTHER_COMPOUND 19443 19446	HCC
T167	OTHER_COMPOUND 19501 19509	surgical
T168	REACTION_PRODUCT 19585 19586	I
T169	OTHER_COMPOUND 19594 19603	sorafenib
T170	OTHER_COMPOUND 19625 19634	Secondary
T171	OTHER_COMPOUND 19751 19752	1
T172	OTHER_COMPOUND 19783 19792	Sorafenib
T173	EXAMPLE_LABEL 19816 19817	4
T174	OTHER_COMPOUND 19988 19991	HCC
T175	OTHER_COMPOUND 20009 20028	sorafenib treatment
T176	OTHER_COMPOUND 20166 20167	I
T177	OTHER_COMPOUND 20168 20171	BSC
T178	OTHER_COMPOUND 20183 20186	BSC
T179	OTHER_COMPOUND 20213 20216	HCC
T180	OTHER_COMPOUND 20250 20259	sorafenib
T181	OTHER_COMPOUND 20307 20316	sorafenib
T182	OTHER_COMPOUND 20440 20443	PCT
T183	OTHER_COMPOUND 20467 20468	I
T184	OTHER_COMPOUND 20469 20472	BSC
T185	OTHER_COMPOUND 20476 20483	placebo
T186	OTHER_COMPOUND 20484 20487	BSC
T187	OTHER_COMPOUND 20830 20849	sorafenib treatment
T188	OTHER_COMPOUND 20914 20915	I
T189	OTHER_COMPOUND 20917 20920	BSC
T190	OTHER_COMPOUND 20933 20936	BSC
T191	OTHER_COMPOUND 20971 20979	advanced
T192	OTHER_COMPOUND 20980 20983	HCC
T193	OTHER_COMPOUND 21027 21046	sorafenib treatment
T194	OTHER_COMPOUND 21072 21081	sorafenib
T195	OTHER_COMPOUND 21178 21181	TTP
T196	OTHER_COMPOUND 21334 21337	HCC
T197	OTHER_COMPOUND 21350 21359	sorafenib
T198	OTHER_COMPOUND 21387 21388	I
T199	OTHER_COMPOUND 21422 21425	BSC
T200	OTHER_COMPOUND 21462 21465	BSC
T201	REACTION_PRODUCT 21510 21598	4-amino-5-fluoro-3- [6-(4-methylpiperazin1 -yl)- 1H-benzimidazol-2-yl]- 1H-quinolin-2one
T202	OTHER_COMPOUND 21821 21906	4-amino-5-fluoro-3-[6-(4-methylpiperazin-l-yl)-lHbenzimidazol-2-yl]-lH-quinolin-2-one
T203	REACTION_PRODUCT 21934 21966	pharmaceutically acceptable salt
T204	EXAMPLE_LABEL 22040 22041	2
T205	EXAMPLE_LABEL 22043 22044	4
T206	REACTION_PRODUCT 22045 22060	amin 5 u r 3 [6
T207	REACTION_PRODUCT 22061 22121	(4 methy piperazin- -y )- H-benzimidaz -2-y ]- H-quin in-2ne
T208	OTHER_COMPOUND 22255 22340	4-amino-5-fluoro-3-[6-(4-methylpiperazin-l-yl)-lHbenzimidazol-2-yl]-lH-quinolin-2-one
T209	OTHER_COMPOUND 22450 22461	sole active
T210	REACTION_PRODUCT 22641 22730	4-amino-5-fluoro-3- [6-(4-methylpiperazin1 -yl)- 1H-benzimidazol-2-yl]- 1H-quinolin-2-one
T211	REACTION_PRODUCT 22826 22911	4-amino-5-fluoro-3-[6-(4methylpiperazin-l-yl)-lH-benzimidazol-2-yl]-lH-quinolin-2-one
T212	OTHER_COMPOUND 23026 23032	active
T213	REACTION_PRODUCT 23150 23242	4-amino-5-fluoro-3 - [6-(4-methylpiperazin1 -yl)- 1 H-benzimidazol-2-yl] - 1 Hquinolin-2-one
T214	REACTION_PRODUCT 23315 23400	4-amino5-fluoro-3-[6-(4-methylpiperazin-l-yl)-lH-benzimidazol-2-yl]-lH-quinolin-2-one
T215	REACTION_PRODUCT 23563 23649	4-amino-5-fluoro-3- [6-(4-methylpiperazin1-yl)- 1H-benzimidazol-2yl]-lH-quinolin-2-one
T216	REACTION_PRODUCT 23745 23813	4-amino-5-fluoro-3- [6-(4-methylpiperazin1 -yl)- 1H-benzimidazol-2WO
T217	OTHER_COMPOUND 23844 23865	yl]-lH-quinolin-2-one
T218	REACTION_PRODUCT 23999 24086	4-amino-5-fluoro-3- [6-(4-methylpiperazin1-yl)- 1H-benzimidazol-2-yl]- 1Hquinolin-2-one
T219	OTHER_COMPOUND 24146 24151	daily
T220	TIME 24186 24192	5 days
T221	TIME 24219 24227	two days
T222	REACTION_PRODUCT 24305 24394	4-amino-5-fluoro-3-[6- (4-methylpiperazin1 -yl)- 1H-benzimidazol-2-yl]- 1H-quinolin-2-one
T223	REACTION_PRODUCT 24750 24837	4-amino-5-fluoro-3- [6-(4-methylpiperazin1-yl)- 1H-benzimidazol-2-yl]- 1Hquinolin-2-one
T224	EXAMPLE_LABEL 24964 24965	9
T225	OTHER_COMPOUND 24984 25069	4-amino-5-fluoro-3-[6-(4-methylpiperazin-l-yl)-lH-benzimidazol-2-yl]-lHquinolin-2-one
T226	OTHER_COMPOUND 25121 25130	sorafenib
T227	EXAMPLE_LABEL 25132 25134	10
T228	REACTION_PRODUCT 25150 25241	or 4-amino-5-fluoro-3- [6-(4-methylpiperazin1 -yl)- 1H-benzimidazol-2-yl]- 1Hquinolin-2-one
T229	OTHER_COMPOUND 25313 25316	HCC
T230	OTHER_COMPOUND 25347 25356	sorafenib
T231	OTHER_COMPOUND 25409 25418	sorafenib
T232	OTHER_COMPOUND 25447 25450	HCC
T233	OTHER_COMPOUND 25467 25476	sorafenib
T234	REACTION_PRODUCT 25499 25584	4-amino-5-fluoro-3-[6-(4-methylpiperazin-l-yl)-lH-benzimidazol-2-yl]-lHquinolin-2-one
T235	TIME 25679 25688	11 months
T236	REACTION_PRODUCT 25711 25799	4-amino-5-fluoro-3- [6-(4-methylpiperazin1 -yl)- 1H-benzimidazol-2-yl]- 1Hquinolin-2-one
T237	TIME 25868 25877	12 months
T238	REACTION_PRODUCT 25930 26021	or 4-amino-5-fluoro-3- [6-(4-methylpiperazin1 -yl)- 1H-benzimidazol-2-yl]- 1Hquinolin-2-one
T239	TIME 26090 26099	13 months
T240	EXAMPLE_LABEL 26101 26103	14
T241	REACTION_PRODUCT 26122 26210	4-amino-5-fluoro-3- [6-(4-methylpiperazin1 -yl)- 1H-benzimidazol-2-yl]- 1Hquinolin-2-one
T242	TIME 26314 26322	6 months
T243	EXAMPLE_LABEL 26324 26326	15
T244	REACTION_PRODUCT 26345 26433	4-amino-5-fluoro-3- [6-(4-methylpiperazin1 -yl)- 1H-benzimidazol-2-yl]- 1Hquinolin-2-one
T245	TIME 26529 26537	7 months
T246	REACTION_PRODUCT 26839 26927	4-amino-5-fluoro-3 - [6-(4-methylpiperazin1 -yl)- 1H-benzimidazol2-yl]-lH-quinolin-2-one
T247	OTHER_COMPOUND 26931 26935	sole
T248	OTHER_COMPOUND 26957 26964	lactate
